• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物流产后门诊随访与电话随访的比较。

Comparing office and telephone follow-up after medical abortion.

作者信息

Chen Melissa J, Rounds Kacie M, Creinin Mitchell D, Cansino Catherine, Hou Melody Y

机构信息

Department of Obstetrics and Gynecology, University of California, Davis, 4860 Y Street, Suite 2500, Sacramento, CA 95817.

Department of Obstetrics and Gynecology, University of California, Davis, 4860 Y Street, Suite 2500, Sacramento, CA 95817.

出版信息

Contraception. 2016 Aug;94(2):122-6. doi: 10.1016/j.contraception.2016.04.007. Epub 2016 Apr 18.

DOI:10.1016/j.contraception.2016.04.007
PMID:27101901
Abstract

OBJECTIVES

Compare proportion lost to follow-up, successful abortion, and staff effort in women who choose office or telephone-based follow-up evaluation for medical abortion at a teaching institution.

STUDY DESIGN

We performed a chart review of all medical abortions provided in the first three years of service provision. Women receiving mifepristone and misoprostol could choose office follow-up with an ultrasound evaluation one to two weeks after mifepristone or telephone follow-up with a scheduled telephone interview at one week post abortion and a second telephone call at four weeks to review the results of a home urine pregnancy test.

RESULTS

Of the 176 medical abortion patients, 105 (59.7%) chose office follow-up and 71 (40.3%) chose telephone follow-up. Office evaluation patients had higher rates of completing all required follow-up compared to telephone follow-up patients (94.3% vs 84.5%, respectively, p=.04), but proportion lost to follow-up was similar in both groups (4.8% vs 5.6%, respectively, p=1.0). Medical abortion efficacy was 94.0% and 92.5% in women who chose office and telephone follow-up, respectively. We detected two (1.2%) ongoing pregnancies, both in the office group. Staff rescheduled 15.0% of appointments in the office group. For the telephone follow-up cohort, staff made more than one phone call to 43.9% and 69.4% of women at one week and four weeks, respectively.

CONCLUSIONS

Proportion lost to follow-up is low in women who have the option of office or telephone follow-up after medical abortion. Women who choose telephone-based evaluation compared to office follow-up may require more staff effort for rescheduling of contact, but overall outcomes are similar.

IMPLICATIONS

Although women who choose telephone evaluation may require more rescheduling of contact as compared to office follow-up, having alternative follow-up options may decrease the proportion of women who are lost to follow-up.

摘要

目的

比较在一家教学机构中,选择门诊或电话随访评估进行药物流产的女性的失访比例、流产成功率及工作人员的工作量。

研究设计

我们对服务提供的前三年中所有进行药物流产的病例进行了图表回顾。接受米非司酮和米索前列醇的女性可以选择在服用米非司酮一至两周后进行门诊超声随访评估,或者选择电话随访,即在流产后一周进行预定的电话访谈,并在四周时进行第二次电话随访以复查家庭尿妊娠试验结果。

结果

在176例药物流产患者中,105例(59.7%)选择门诊随访,71例(40.3%)选择电话随访。与电话随访患者相比,门诊评估患者完成所有必要随访的比例更高(分别为94.3%和84.5%,p = 0.04),但两组的失访比例相似(分别为4.8%和5.6%,p = 1.0)。选择门诊和电话随访的女性药物流产成功率分别为94.0%和92.5%。我们在门诊组中检测到2例(1.2%)持续妊娠。门诊组工作人员重新安排了15.0%的预约。对于电话随访队列,工作人员分别对43.9%和69.4%的女性在一周和四周时拨打了不止一个电话。

结论

在药物流产后可选择门诊或电话随访的女性中,失访比例较低。与门诊随访相比,选择电话评估的女性可能需要工作人员付出更多努力来重新安排联系,但总体结果相似。

启示

尽管与门诊随访相比,选择电话评估的女性可能需要更多地重新安排联系,但提供替代随访选项可能会降低失访女性的比例。

相似文献

1
Comparing office and telephone follow-up after medical abortion.药物流产后门诊随访与电话随访的比较。
Contraception. 2016 Aug;94(2):122-6. doi: 10.1016/j.contraception.2016.04.007. Epub 2016 Apr 18.
2
Feasibility of telephone follow-up after medical abortion.医学流产后电话随访的可行性。
Contraception. 2010 Feb;81(2):143-9. doi: 10.1016/j.contraception.2009.08.008. Epub 2009 Sep 30.
3
Efficacy and safety of medical abortion using mifepristone and buccal misoprostol through 63 days.米非司酮与口腔含服米索前列醇用于63天内药物流产的有效性和安全性。
Contraception. 2015 Apr;91(4):269-73. doi: 10.1016/j.contraception.2015.01.005. Epub 2015 Jan 13.
4
Self-assessment of medical abortion outcome using symptoms and home pregnancy testing.使用症状和家用妊娠试验对药物流产结果进行自我评估。
Contraception. 2018 Apr;97(4):324-328. doi: 10.1016/j.contraception.2017.12.004. Epub 2017 Dec 11.
5
Prospective study of home use of mifepristone and misoprostol for medical abortion up to 10weeks of pregnancy in Kazakhstan.哈萨克斯坦关于在家使用米非司酮和米索前列醇进行孕期10周以内药物流产的前瞻性研究。
Int J Gynaecol Obstet. 2016 Sep;134(3):268-71. doi: 10.1016/j.ijgo.2016.02.018. Epub 2016 May 26.
6
Acceptability of suction curettage and mifepristone abortion in the United States: a prospective comparison study.美国吸刮术和米非司酮流产的可接受性:一项前瞻性比较研究。
Am J Obstet Gynecol. 2000 Jun;182(6):1292-9. doi: 10.1067/mob.2000.106183.
7
Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol.米非司酮与米索前列醇用于停经9 - 13周的终止妊娠。
Lancet. 1998 Aug 15;352(9127):542-3. doi: 10.1016/S0140-6736(05)79250-3.
8
[The efficacy and acceptability of mifepristone medical abortion with home administration misoprostol provided by private providers linked with the hospital: a prospective study of 433 patients].[由与医院相关的私人提供者提供在家服用米索前列醇的米非司酮药物流产的疗效和可接受性:对433例患者的前瞻性研究]
Gynecol Obstet Fertil. 2005 Apr;33(4):220-7. doi: 10.1016/j.gyobfe.2005.02.021. Epub 2005 Mar 22.
9
Acceptability and feasibility of 400 μg buccal misoprostol after 200 mg mifepristone for early medical abortion in Georgia.在格鲁吉亚,米非司酮200毫克后口服400微克米索前列醇用于早期药物流产的可接受性和可行性。
Eur J Contracept Reprod Health Care. 2016 Oct;21(5):367-71. doi: 10.1080/13625187.2016.1211632. Epub 2016 Jul 22.
10
Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.妊娠 50-63 天行门诊在家自行应用米索前列醇药物流产与妊娠<50 天行药物流产的比较。
Hum Reprod. 2010 May;25(5):1153-7. doi: 10.1093/humrep/deq037. Epub 2010 Feb 19.

引用本文的文献

1
The use of telemedicine services for medical abortion.远程医疗服务在药物流产中的应用。
Cochrane Database Syst Rev. 2025 Jun 4;6(6):CD013764. doi: 10.1002/14651858.CD013764.pub2.
2
Self-testing for pregnancy: a systematic review and meta-analysis.自我妊娠检测:系统评价和荟萃分析。
BMJ Open. 2022 Feb 28;12(2):e054120. doi: 10.1136/bmjopen-2021-054120.
3
Comparing telemedicine to in-clinic medication abortions induced with mifepristone and misoprostol.比较远程医疗与使用米非司酮和米索前列醇进行的门诊药物流产。
Contracept X. 2020 Apr 11;2:100023. doi: 10.1016/j.conx.2020.100023. eCollection 2020.
4
Special ambulatory gynecologic considerations in the era of coronavirus disease 2019 (COVID-19) and implications for future practice.特殊的 2019 冠状病毒病(COVID-19)时代下的 门诊妇科注意事项及其对未来实践的影响。
Am J Obstet Gynecol. 2020 Sep;223(3):372-378. doi: 10.1016/j.ajog.2020.06.006. Epub 2020 Jun 6.
5
Telemedicine for Family Planning: A Scoping Review.计划生育领域的远程医疗:范围综述。
Obstet Gynecol Clin North Am. 2020 Jun;47(2):287-316. doi: 10.1016/j.ogc.2020.02.004. Epub 2020 Apr 29.
6
Commentary: No-test medication abortion: A sample protocol for increasing access during a pandemic and beyond.评论:非检测药物流产:大流行期间及之后增加可及性的示例方案。
Contraception. 2020 Jun;101(6):361-366. doi: 10.1016/j.contraception.2020.04.005. Epub 2020 Apr 16.
7
Telemedicine for medical abortion: a systematic review.远程医疗用于药物流产:系统综述。
BJOG. 2019 Aug;126(9):1094-1102. doi: 10.1111/1471-0528.15684. Epub 2019 Apr 25.